Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer

Abstract

These observations underscore the critical role of timing and disease context in order to optimize the therapeutic efficacy of immune modulators combined with androgen ablation, for which the presurgical neoadjuvant setting may be ideal. Our findings warrant future prospective validation, which is currently underway.